GMPDDS2024

Vladimir Muzykantov received an MD (Internal Medicine) in 1980 from the First Moscow Medical School and Ph.D. (Biochemistry) in 1986 from the USSR National Cardiology Research Center). From 1986 to 1993 he conducted research in that Research Center in Moscow. Muzykantov moved to PENN in 1993 and in 2010 became a Full Tenured Professor and Vice-Chair of the Department of Systems Pharmacology and Translational Therapeutics. In 2010 he established the Center for Targeted Therapeutics and Translational Nanomedicine (CT3N) at PENN, which he directs. Since 2022 he is the Scientific Director of Nanocarrier Targeting Core and Targeting Theme Leader in PENN RNA Innovation Institute (Dr. Drew Weissman, Director). He published ~280 papers and edited a book “Biomedical Aspects of Drug Targeting” (Kluwer, 2003). Honors include: AHA Established Investigator (1996), AHA Bugher Stroke Award (2000), Chair of Transatlantic Airway Conference on Targeting Molecular Signatures in Lungs (Luzerne, 2009), Co-Chairing Gordon Conference on Drug Carriers (2012) and HLBI Division of Lung Diseases Workshop “Precision Therapeutics Delivery for Lung Diseases” (2014), Invited, Keynote and Plenary talks in many international conferences. In 2022, he was elected to the Fellowship of the Controlled Release Society. In 2023, Muzykantov has been appointed the inaugural the Founders Endowed Chair Professor of Nanoparticles Research at PENN. His research focuses on drug delivery by blood cells and endothelial targeting for treatment ischemia-reperfusion (AMI and stroke) inflammation, thrombosis, bleeding, hematologic, neurologic, cardiologic and respiratory maladies.

Tanaka worked for TERUMO Co. (Leading Medical Devices and Tissue Engineering Company in Japan). In 2000 He moved to Hokkaido University and in 2007 he moved to Tohoku University. Stents covered with the self-organized porous 3D films are commercially available in the world clinical market. He was a Visiting Scientist, at Dept. of New Materials and Biosystems, Max-Planck-Institute (2008-2009). In 2009 he was awarded a full professorship at Yamagata University. He became a leader of Funding Program for Next Generation World-Leading Researchers (NEXT Program, Japan 2011-2014). Since 2015, he has been at Kyushu University as a full Professor. Since 2019, he was a leader of JSPS Internationlal Joint Research Program (2019-present). Thus far, he has published over 200 papers in peer reviewed journals (H-index 56), 50 book chapter, 125 others, 250 patents, more than 100 invited talks at International Conferences including Society for Biomaterials 2019 Annual Meeting Exposition, Seattle). He is an executive director of the Japanese Society for Biomaterials, a committee member at IUPAC polymer division, and organized many international conferences as an international advisory board. He received the Japanese Society for Biomaterials Award, the SPSJ Asahi Kasei Award, and the British Council PMI2 Connect-Research Co-operation (UK) Award.

Professor Sivakumar Manickam is a Chemical Engineer renowned for his expertise in process engineering related to nanomaterials, with a special focus on nanopharmaceuticals. He boasts an extensive career spanning over 25 years in this specialized field. Presently, he holds a position at theUniversity of Technology Brunei (UTB) in Brunei, having previously worked at the University ofNottingham, International Campus in Malaysia. Prof. Sivakumar's research focuses on developing cavitation-based reactors to produce technologically significant nanomaterials. His work also encompasses environmentally friendly methods for natural product extraction, water treatment, the formulation of pharmaceutical nanoemulsions, and innovative carbon nanomaterials to create biosensors for early diagnosis of conditions like cancer and diabetes. While at the University of Nottingham, he served in various leadership capacities, including Director of Research, Founding Director for the Centre for Nanotechnology and Advanced Materials, Head of the Manufacturing and Industrial Research Division, and Associate Dean for Research and Knowledge Exchange. At UTB, he currently serves as Deputy Dean (Research) of the Faculty of Engineering. Throughout his illustrious career, Prof. Sivakumar has successfully managed and completed over 20 projects funded by industry and government entities. He has also supervised more than 50 students in various research projects. His significant contributions to the field are reflected in his extensive publication record, which includes over 250 peer-reviewed papers in reputable journals and conferences. His scholarly impact is underscored by a notable h-index of 59, as per Scholar Google. Additionally, Prof. Sivakumar holds the prestigious position of Executive Editor for the Ultrasonics Sonochemistry Journal. His affiliations extend to service on the Asia Oceania Sonochemical Society board. Furthermore, he has been recognized as a Fellow of the Higher Education Academy (UK) and a Fellow of the Royal Society of Chemistry (FRSC).

Dr. Xinguang Cui is an associate professor in the Huazhong University of Science and Technology, China. He is the lead of the Lab of respiratory multiphase flows. He received a bachelor degree in Beihang University, China at 2005, master degree in Tsinghua University, China at 2008 respectively. At 2012, he received his Ph.D degree in the subject of fluid mechanics from University of Heidelberg, Germany at 2012. He conducted research work related to numerical modeling the areas of fluid mechanics, atmosphere science and bio-energy in University of Heidelberg, Nanyang Technological University and Lawrence Berkeley National Lab. Presently, he is interested in applying in numerical methods to solve industrial and scientific problems in the disciplines of medical industry, indoor environment and energy, specially related to respiratory multiphase flows. Until now, he has published more than 40 peer-reviewed journal paper, and more than 20 conference papers.

Dr. Natalya Rekoslavskaya graduated from Irkutsk State University at the Department of plant physiology, cell biology and genetics. She joined the Siberian Institute of Plant Physiology and Biochemistry of the Siberian Branch of Russian Academy of Sciences in Irkutsk where still is working up to now. She educated at Michigan State University (USA) and there was isolated the main gene of auxin metabolism, the iaglu gene encoded the synthetase of indoleacetyl glucose under supervision of professor Robert S. Bandurski and after was working in Milan (CNR). Under supervision of professor Rurik K. Salyaev she participated in the project of development of edible vaccines against HIV and HBV. She was a Professor in Irkutsk State University at the Department of plant physiology, cell biology and genetics during 26 years. Now she is the Head of the State Project "The development of innovative therapeutic vaccines created on the basis of plant expression system against cervical cancer and other dangerous papillomatoses" of SB RAS.

Dr. Jitendra Gupta completed his M. Pharm. (Pharmaceutics) from Dr. APJ Abdul Kalam Technical University (Formerly U.P.T.U.), Doctor of Philosophy (PhD) from National Institute of Medical Science, Jaipur, and qualified GATE (93.32 percentile) and D.P.Q.C.&Q.A.M., IPER, Pune, Maharashtra. He has approx. 18 years of research, academic and administrative experience @ Institute of Pharmaceutical Research, GLA University (NAAC A+ Grade, NIRF 54 rank & 12 B Status), Mathura. He has awarded “Shikshak Gaurav Ratna Award" 2023 & "Shikshak Sri Award” 2018 by “First Vice President” of Nepal Government, New Delhi. He has also awarded Young Scientist Award, Eminent Teacher Award, Best Students PhD award, Best paper publication, Best paper presentation and Best poster presentation award, and Fellow member of FRSH, FICPHS. He is “Ambassador” of Bentham Science in 2020 and also called for a Guest lecture and speaker The M.S. University, Baroda (Gov. University). He has also been called as a speaker in International and National Conferences/FDP. He has been serving as an Editorial Board Member and Reviewer of International/National Journals indexing in SCI, and SCOPUS. He has more than 100 publications indexed in SCI and Scopus index journals with high impact factors (more than 10.3) and over 100 posters/abstracts at International/National conferences. He has guided 14 postgraduate students and seventy-seven undergraduate students as the main supervisor. He is guiding 05 PhD students. He has published four books and three book chapters in Springer Nature, Singapore, published 10 patents, 3 patents granted, and two IEDC-DST sponsored projects. He has knowledge and experience in NAAC, NIRF, etc. His areas of research interest include nanotechnology, microtechnology, nano-micelles micellar solubilization technique), solid dispersion, transdermal patch; Standardization of polyherbal formulations; Medicinal plants and their role in health and disease management, Molecular Mechanisms and Antioxidants, Anti-diarrhoeal, Wound healing, Antitussive, Cough suppressant, Antimicrobial, Anti-ischemic, Anticancer and also isolations and identification of phytochemicals from local natural resources.

Huang Wei Ling, born in Taiwan, raised and graduated in medicine in Brazil, specialist in infectious and parasitic diseases, a General Practitioner and Parenteral and Enteral Medical Nutrition Therapist. Once in charge of the Hospital Infection Control Service of the City of Franca’s General Hospital, she was responsible for the control of all prescribed antimicrobial medication and received an award for the best paper presented at the Brazilian Hospital Infection Control Congress in 1998. Since 1997, she works with the approach and treatment of all chronic diseases in a holistic way, with treatment guided through the teachings of Traditional Chinese Medicine and Hippocrates. Researcher in the University of São Paulo, in the Ophthalmology department from 2012 to 2013.Author of the theory Constitutional Homeopathy of the Five Elements Based on Traditional Chinese Medicine. Author of more than 100 publications about treatment of variety of diseases rebalancing the internal energy using Hippocrates thoughts.

Dr. Subhash C. Mandal, Ph.D., is Professor at Division of Pharmacognosy, Department of Pharmaceutical Technology, Jadavpur University, Kolkata, India. Professor Mandal is the recipient of prestigious awards including Endeavour Research Award, Government of Australia; Distinguished Education & Research Award, AAiPS, United States; Talented Scientist Award, University of Colombo, Sri Lanka; SAARC Fellowship Award, University Grants Commission (UGC), Bangladesh; Fast Track Young Scientist Award, Department of Science and Technology, UGC Research Award, India and Outstanding University Teachers’ Award, Department of higher education Government of West Bengal, India. He has supervised more than 36 doctoral and 25 M. Pharm scholars and has more than 320 research publications, several patents, books, and book chapters to his credit. Professor Mandal has delivered more than 50 research presentations around the globe, has chaired many international conferences, and successfully completed more than 10 government funded research projects. He is reviewer and board member of several high-impact journals and is a recognized host scientist for many international research programs with developing countries sponsored by the Indian Government. He has visited more than 30 countries for various scientific deliberations, collaborations, and exchange programs.

After studying biochemistry at the Masaryk University in Brno, he devoted himself to the development of immunopharmacology and immunotherapy in the field of recombinant and genetic vaccines. Part of his professional interest is the physical chemistry of nanosystems and nanotechnology for medical applications, especially in the field of targeted antitumor drugs based on nanoliposomes. In particular, in the field of modern recombinant vaccines, molecular adjuvants and biocompatible nanosystems, nanofibre-based mucoadhesive films and application of click chemistry for vaccine construction, he belongs among the pioneers in the field. He is a founding member of the Czech Society for Cell and Gene Therapy, a committee member and chairman of the society. Prof. J. Turánek is a successful researcher or co-researcher of 16 large complex projects. For his work, he received a number of awards (e.g. two TAČR awards, the Minister of Agriculture Award and Minister of Health Award ) and a nomination for the Czech Head Award. In the period 2000-2018, he was the organizer and chairman of the scientific committee of a series of 11 international conferences "Drug Delivery Systems". Currently, J. Turánek coordinates the cooperation of the Department of Immunology Palacky University Olomouc with other academic and university workplaces and Czech pharmaceutical companies in the development of modern vaccines, adjuvants and recombinant therapeutic (projects “Recombinant Therapeutics for Medicine” and “Therapeutic Recombinant Proteins”). He is the head of R&D at the research organization NEXARS, which is focused on development of recombinant vaccines.

Prof. Irena Kostova is one of the World’s Top 1% of scientists according to Stanford University's ranking of scientists with the greatest contribution to the development of modern science. She graduated from Mendeleev University in Moscow with the highest grade. Defended her PhD and DSc theses at MU-Sofia where she is currently a full professor at Chemistry Department. Graduated her second specialization “Theoretical bases of medical chemistry” at MU-Sofia. Her research interests include the developmental work in theoretical and coordination chemistry, vibrational spectroscopy, pharmacological investigations of biologically active compounds etc. Author of about 200 publications with high impact factor and h-index, several textbooks, education book materials and monographs with around 7000 citations in indexed journals. She has been a lecturer at renowned universities in India, Austria, Italy, Romania, Spain, Slovakia etc. Member of the organizing committees of over 30 international conferences. She is an Editor of 7 prestigious international scientific journals, a member of the Editorial Boards of over 25 international journals and a reviewer for numerous high-ranking journals and international projects. She has created and maintains collaborations with a number of European universities in the framework of joint research projects and European programs.

Seda ÜNSALAN graduated from Marmara University Faculty of Pharmacy in 1993. After graduation, she worked as an academician at the same university in pharmaceutical chemistry department . She had a scholarship from TÜBİTAK Münir Birsel Foundation during her PhD. She had been in Germany for two years. In the mean time she won a scholarship from DAAD (Deutscher Akademischer Austaushdienst). After returning from Germany, she took the exam for associate professor and passed it. At the end of 2008, she had a new position as clinical research chief at Nobel Pharmaceuticals and As of 2016, she managed the clinical research department of Nobel Pharmaceutical. In 2021, she retired from an amazing professional journey of 14.5 years in academia and 12.5 years at Nobel Pharmaceuticals. She has been teaching at Istanbul Medipol University Faculty of Pharmacy since 2022 as a professor.

Dr. Annie FRELET-BARRAND studied biochemistry at the University of Franche-Comté (France) and was graduated as MS in 1998. In 2006, she received her PhD degree on MP characterization at the Institute of Plant Biology, Zurich. During her postdoctoral fellowship (CEA Grenoble, France), she developed L. lactis system for functional characterization of MPs. In 2009, she became CNRS Researcher at CEA Saclay, studying MPs involved in liver detoxification. In 2015, she integrated the Institute FEMTO-ST and is now producing and characterizing diverse biological elements from proteins, (extracellular & synthetic) vesicles to bacteria and cells. She published 22 research articles and 4 book chapters (h=17).

Dr. Yurdasiper obtained her BSc and MSc degree in Faculty of Pharmacy from Ege University, Izmir, Turkey and respectively, followed by a Ph. D degree from Department of Pharmaceutical Technology, Ege University, studying on nanogel delivery system of nonsteoridal antiinflammatory drugs: preparation, characterization and invitro- invivo studies on dermal drug delivery. She has studied as a Phd Student with TUBITAK Scholarship in Cardiff University, Welsh School of Pharmacy, Cardiff, UK. Her work is focused on dry powder inhalers, dermal delivery (topical, transdermal drug systems), controlled release formulations (nanoparticles, microparticles) for drug delivey and nanomedicine in pulmonary delivery. She is Editor in chief in American Journal of Drug Delivery and Therapeutics also Editor and on the Editorial Board of several International Journals. She has filed a National patent on dry powder inhaler formulation and she is a member of Turkish Pharmaceutical Technology Scientists' Association (TUFTAD), Turkish Pharmacists' Association (TEB), Controlled Release Society (CRS) and American Association of Pharmaceutical Scientists (AAPS). She has been working as a researcher in Department of Pharmaceutical Technology, Ege University. Her current research interest focus on development of novel nanomedicine including polymers and in vitro-in vivo evaluation for treatment of pulmonary diseases.

Dr. Mohammad F. Bayan is working as an Associate Professor of Pharmaceutics at faculty of Pharmacy in Philadelphia University, Amman, Jordan. The major focus of Dr. Bayan's research involves the development of controlled and triggered drug delivery systems using advanced and novel technologies. His work involves organic synthesis, synthesis and characterization of polymeric smart materials and performing drug release studies. He is author of more than 25 publications and received funding from national and international grants (Philadelphia University, Jordan; Project number 511/34/100 PU, King Khalid University, Saudi Arabia; Project number RGP.2/31/43 and Najran University, Saudi Arabia; Project number NU/RG/MRC/12/20). Dr Bayan has presented his work at numerous international and national conferences such as the 10th world meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology; 6th APS International PharmSci and 38th All Ireland Schools of Pharmacy Research Conference.

Principal Investigator and Senior Researcher, Dr. Ausra Baradoke, boasts a rich academic journey, intertwined with over a decade of hands-on research across eight distinguished scientific groups, including the prestigious University of Oxford. Her illustrious educational pursuit culminated in a PhD, fostered through a collaborative endeavor between the Center for Physical and Technological Sciences, Dublin City University, and Trinity College Dublin, all reputable Irish institutions. Dr. Baradoke's tenure at the University of Oxford was notably marked by the acquisition of Innovate UK funding, which propelled her towards authoring two high-impact publications and contributing to a pioneering patent in the realm of electrochemical sensors. Her scholarly voyage has further spawned seven revered publications in high-caliber international scientific journals, a patent application, and the dissemination of her research in 27 conferences, manifesting a knack for bridging the scientific community and the public domain. The narrative of Dr. Baradoke's research and experimental development (R&D) chronicles a series of projects bankrolled by esteemed bodies like the Education Exchange Support Fund, Erasmus +, Innovate UK, and Mobilitas Pluss. Significant milestones include the successful orchestration of the "Intellect LT" project (VP2-1.3-uM-02-K-04-122), along with substantial contributions to METASENS (CH-3-SMM-01-11) and G ‐ SUPERCAP (3200-P325, LAT-16002) initiatives. Venturing beyond the academic sphere, Dr. Baradoke honed her expertise in sensor development through collaborative endeavors with private sector entities, notably ERUMPO LTD and later, Osler Diagnostics LTD. Dr. Baradoke's foray into academia also entails a rich tapestry of mentorship, where she has been instrumental in nurturing students at varying academic stages (bachelor's, master's, doctoral) across a spectrum of esteemed universities: Vilnius University, Dublin City University, Trinity College Dublin, University of Tartu, and University of Oxford. This facet of her journey underscores a deep-seated commitment to fostering the next generation of thought leaders, particularly within the pharmacy and sensor development sectors.

Chikezie Kennedy Kalu is currently a PhD Student at the Department of Management Science and Engineering, School of Management; Jiangsu University, China. His field of research is Technology and Innovation Management. He is from Nigeria and has a B.Eng. in Electronics Engineering from The University of Nigeria Nsukka; Enugu State, Nigeria (UNN) and a Masters (with Distinction) in Communication Engineering from The University of Manchester, UK. He has also had professional work experiences cutting across the Industries of: Telecom Engineering, Retail, Education, Oil and Gas, ICT and Logistics.